Article

Expression of BMP and Actin Membrane Bound Inhibitor Is Increased during Terminal…

Stem Cells International · 2016 · Christian G. Pfeifer, author Alexandra Karl, author Arne Berner, author Johannes Zellner, author Paul Schmitz, author Markus Loibl, author Matthias Koch, author Peter Angele, author Michael Nerlich, author Michael B. Mueller, author Andrea Ballini, Academic Editor

Key facts

Title Expression of BMP and Actin Membrane Bound Inhibitor Is Increased during Terminal Differentiation of MSCs
First author Christian G. Pfeifer, author Alexandra Karl, author Arne Berner, author Johannes Zellner, author Paul Schmitz, author Markus Loibl, author Matthias Koch, author Peter Angele, author Michael Nerlich, author Michael B. Mueller, author Andrea Ballini, Academic Editor
Journal Stem Cells International
Published Sep 2, 2016
DOI 10.1155/2016/2685147
Devices mentioned K023020, K103302
Product codes mentioned GIA, IXA, JCJ, KIP, KIT, NDS, NJT, OOI

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature